Article | January 10, 2023

The Challenges And Opportunities Of Antibody Therapies

GettyImages-1441786721-mAb-Antibody-monoclonal

Antibody-based therapeutics, which are comprised of antibodies that target and attack specific antigens, have dramatically risen in popularity. Antibody-based oncology therapies and COVID-19 treatments are in particularly high demand.

This leaves suppliers with the challenging task of quickly developing and manufacturing antibody therapies at scale. In this article, we break down the hurdles of antibody development and manufacturing and discuss exciting antibody developments in the near future.

Key topics covered:

  • Significant Complexities of Antibody Development
  • Challenges in mAb Manufacturing
  • Antibody Therapies on the Horizon

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online